Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Gilead Sciences
GILD
|
+$238M |
| 2 |
Johnson & Johnson
JNJ
|
+$224M |
| 3 |
MON
Monsanto Co
MON
|
+$219M |
| 4 |
AET
Aetna Inc
AET
|
+$215M |
| 5 |
Broadcom
AVGO
|
+$179M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
+$242M |
| 2 |
Microsoft
MSFT
|
+$232M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$205M |
| 4 |
Home Depot
HD
|
+$188M |
| 5 |
Nike
NKE
|
+$187M |
Sector Composition
| 1 | Financials | 14.12% |
| 2 | Technology | 13.1% |
| 3 | Healthcare | 12.08% |
| 4 | Industrials | 11% |
| 5 | Consumer Staples | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Actinium Pharmaceuticals
ATNM
$50.2M
| $100K | ﹤0.01% |
+3,818
| New | +$100K |
|
|
ACCS
3102
ACCESS Newswire Inc.
ACCS
$42.1M
| $98K | ﹤0.01% |
+10,900
| New | +$98K |
|
3103
Eletrobras Common Shares
EBR
$19.1B
| $97K | ﹤0.01% |
+14,200
| New | +$97K |
|
3104
IT Tech Packaging
ITP
$4.53M
| $97K | ﹤0.01% |
8,340
-470
| -5% | -$5.47K |
|
|
BYU
3105
DELISTED
BAIYU Holdings, Inc. Common Stock
BYU
| $97K | ﹤0.01% |
70
-1
| -1% | -$1.39K |
|
|
AIM
3106
AIM ImmunoTech Inc.
AIM
$7.02M
| $97K | ﹤0.01% |
32
-4
| -11% | -$12.1K |
|
|
AFMD
3107
DELISTED
Affimed
AFMD
| $92K | ﹤0.01% |
5,120
-2,290
| -31% | -$41.1K |
|
|
GPUS
3108
Hyperscale Data, Inc.
GPUS
$11M
| – | – |
0
| – | -$112K |
|
|
EMXX
3109
DELISTED
Eurasian Minerals Inc
EMXX
| $92K | ﹤0.01% |
88,900
-21,400
| -19% | -$22.1K |
|
3110
Nortech Systems
NSYS
$25.9M
| $91K | ﹤0.01% |
23,300
+4,100
| +21% | +$16K |
|
|
QBAK
3111
DELISTED
Qualstar Corp
QBAK
| $91K | ﹤0.01% |
31,002
+3,600
| +13% | +$10.6K |
|
3112
RAVE Restaurant Group
RAVE
$47.3M
| $90K | ﹤0.01% |
47,900
+28,400
| +146% | +$53.4K |
|
3113
Nomura Holdings
NMR
$21.9B
| $89K | ﹤0.01% |
+15,100
| New | +$89K |
|
|
SSY
3114
DELISTED
SunLink Health Systems
SSY
| $89K | ﹤0.01% |
73,600
+8,200
| +13% | +$9.92K |
|
|
GNVC
3115
DELISTED
GenVec, Inc.
GNVC
| $89K | ﹤0.01% |
27,760
+9,310
| +50% | +$29.8K |
|
3116
US Energy Corp
USEG
$39.8M
| $88K | ﹤0.01% |
6,898
+430
| +7% | +$5.49K |
|
|
ACUR
3117
DELISTED
Acura Pharmaceuticals Inc
ACUR
| $87K | ﹤0.01% |
113,220
+31,300
| +38% | +$24.1K |
|
3118
Eltek
ELTK
$68.1M
| $86K | ﹤0.01% |
21,880
+240
| +1% | +$943 |
|
3119
TROOPS Inc
TROO
$150M
| $86K | ﹤0.01% |
22,825
-900
| -4% | -$3.39K |
|
3120
Mexco Energy
MXC
$18M
| $85K | ﹤0.01% |
+17,000
| New | +$85K |
|
|
NLST
3121
DELISTED
Netlist, Inc.
NLST
| $84K | ﹤0.01% |
81,900
-165,700
| -67% | -$170K |
|
3122
NovaBay Pharmaceuticals
NBY
$14M
| $83K | ﹤0.01% |
21
-9
| -30% | -$35.6K |
|
|
BIOL
3123
DELISTED
Biolase, Inc.
BIOL
| $83K | ﹤0.01% |
5
+2
| +67% | +$33.2K |
|
|
ATYR
3124
aTyr Pharma
ATYR
$513M
| $82K | ﹤0.01% |
2,721
-2,222
| -45% | -$67K |
|
3125
Nova Lifestyle
NVFY
$66.5M
| $81K | ﹤0.01% |
+1,682
| New | +$81K |
|